Nifty

:

22040.45

Sensex

:

72720.10

44.60 (0.20%)
231.11 (0.32%)

Login

Nifty
Sensex

:
:

22040.45
72720.10

44.60 (0.20%)
231.11 (0.32%)

Adline Chem Lab Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 524604 | NSE: Not Listed

Watchlist

NSE BSE

27.27

12-Apr-2024

Open
High
Low
Previous Close

27.27
27.27
27.27
28.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

200
5454
28.97
5.40

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

15.95
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17.32
N/A
-9.51

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-100.00
-100.00
-100.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
28.31

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
48.95

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-2.10
-2.10
-1.72

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-13.48
-26.69
-31.08

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.02 -100.00%
Expenses 0.00 0.41 -100.00% 0.03 0.29 -89.66% 0.08 0.01 700.00% 0.09 0.12 -25.00%
EBITDA 0.00 -0.41 - -0.03 -0.29 - -0.08 -0.01 - -0.09 -0.10 -
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -485.00%
Other Income 0.01 0.39 -97.44% 0.00 0.53 -100.00% 0.00 0.00 0 0.08 0.02 300.00%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.09 -100.00% 0.00 -0.42 -
PBT 0.00 -0.02 - -0.03 -4.10 - -0.08 -0.10 - -0.01 1.48 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 -0.02 - -0.03 -4.10 - -0.08 -0.10 - -0.01 1.48 -
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7,405.00%
EPS 0.01 -0.04 - -0.05 -6.95 - -0.14 -0.17 - -0.02 2.51 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 0.00 0.00 0.74 6.33 6.59 5.59 8.10 16.86 16.67 15.02 13.45 Net Sales Growth -100.00% -100% -88.31% -3.95% 17.89% -30.99% -51.96% 1.14% 10.99% 11.67% Cost Of Goods Sold 0.00 0.26 0.48 3.03 4.88 1.42 4.61 12.75 13.05 11.09 8.92 Gross Profit 0.00 -0.26 0.26 3.30 1.72 4.17 3.49 4.11 3.61 3.94 4.53 GP Margin 0.00% 0 35.14% 52.13% 26.10% 74.60% 43.09% 24.38% 21.66% 26.23% 33.68% Total Expenditure 0.20 0.80 1.03 6.56 9.92 5.05 7.40 15.64 16.23 14.08 12.43 Power & Fuel Cost - 0.00 0.01 0.03 0.07 0.09 0.10 0.16 0.16 0.14 0.26 % Of Sales - 0 1.35% 0.47% 1.06% 1.61% 1.23% 0.95% 0.96% 0.93% 1.93% Employee Cost - 0.05 0.17 1.56 1.78 1.33 1.20 1.15 1.38 1.20 1.30 % Of Sales - 0 22.97% 24.64% 27.01% 23.79% 14.81% 6.82% 8.28% 7.99% 9.67% Manufacturing Exp. - 0.00 0.04 0.10 0.34 0.08 0.13 0.19 0.18 0.15 0.15 % Of Sales - 0 5.41% 1.58% 5.16% 1.43% 1.60% 1.13% 1.08% 1.00% 1.12% General & Admin Exp. - 0.07 0.15 0.83 0.91 0.53 0.27 0.33 0.26 0.37 0.53 % Of Sales - 0 20.27% 13.11% 13.81% 9.48% 3.33% 1.96% 1.56% 2.46% 3.94% Selling & Distn. Exp. - 0.00 0.05 0.41 0.45 0.56 0.27 0.15 0.27 0.22 0.24 % Of Sales - 0 6.76% 6.48% 6.83% 10.02% 3.33% 0.89% 1.62% 1.46% 1.78% Miscellaneous Exp. - 0.42 0.12 0.61 1.50 1.03 0.81 0.91 0.93 0.89 0.24 % Of Sales - 0 16.22% 9.64% 22.76% 18.43% 10.0% 5.40% 5.58% 5.93% 7.66% EBITDA -0.20 -0.80 -0.29 -0.23 -3.33 0.54 0.70 1.22 0.44 0.94 1.02 EBITDA Margin 0.00% 0 -39.19% -3.63% -50.53% 9.66% 8.64% 7.24% 2.64% 6.26% 7.58% Other Income 0.09 1.00 0.18 0.01 0.02 0.29 0.38 0.08 0.11 0.08 0.02 Interest 0.00 0.00 0.01 0.03 0.02 0.07 0.34 0.32 0.44 0.48 0.57 Depreciation 0.00 0.09 0.35 1.02 0.42 0.73 0.73 0.96 0.09 0.51 0.46 PBT -0.12 0.11 -0.47 -1.28 -3.75 0.03 0.01 0.01 0.02 0.03 0.01 Tax 0.00 0.00 -0.05 0.00 0.26 0.00 0.01 0.00 0.01 0.01 0.00 Tax Rate 0.00% 0.00% -7.46% 0.00% -7.41% 0.00% 100.00% 0.00% 50.00% 33.33% 0.00% PAT -0.12 -4.23 0.72 -1.28 -3.76 0.03 0.00 0.01 0.01 0.02 0.01 PAT before Minority Interest -0.12 -4.23 0.72 -1.28 -3.76 0.03 0.00 0.01 0.01 0.02 0.01 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.00% 0 97.30% -20.22% -57.06% 0.54% 0% 0.06% 0.06% 0.13% 0.07% PAT Growth 0.00% - - - - 0 -100.00% 0.00% -50.00% 100.00% EPS -0.20 -7.17 1.22 -2.17 -6.37 0.05 0.00 0.02 0.02 0.03 0.02

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds -1.57 2.65 1.93 3.21 7.03 7.03 7.04 7.06 7.06 7.06 Share Capital 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85 5.85 Total Reserves -7.42 -3.20 -3.92 -2.64 1.18 1.18 1.19 1.21 1.21 1.21 Non-Current Liabilities 0.29 0.30 0.40 0.35 0.29 4.06 4.45 4.56 5.85 4.52 Secured Loans 0.00 0.00 0.00 0.00 0.00 3.77 4.15 4.29 5.57 4.32 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.29 0.30 0.36 0.30 0.25 0.24 0.25 0.23 0.23 0.16 Current Liabilities 1.34 1.93 3.30 4.02 14.52 12.27 9.47 6.80 5.71 4.94 Trade Payables 0.00 0.45 0.24 0.56 1.70 0.80 1.72 1.48 1.31 1.11 Other Current Liabilities 0.00 0.02 0.31 0.36 7.47 3.92 1.95 0.59 0.62 1.37 Short Term Borrowings 1.33 1.32 2.50 2.85 5.35 7.55 5.79 4.72 3.68 2.37 Short Term Provisions 0.00 0.15 0.25 0.25 0.01 0.00 0.00 0.01 0.10 0.09 Total Liabilities 0.06 4.88 5.63 7.58 21.84 23.36 20.96 18.42 18.62 16.52 Net Block 0.00 4.43 3.64 4.78 11.99 12.45 12.68 10.27 10.08 8.17 Gross Block 0.00 5.57 5.63 6.29 19.46 19.18 18.65 15.27 15.06 12.62 Accumulated Depreciation 0.00 1.14 1.99 1.51 7.48 6.73 5.98 5.00 4.98 4.45 Non Current Assets 0.00 4.44 3.65 4.82 12.02 12.51 12.75 11.69 11.51 9.57 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.20 0.20 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.01 0.01 0.04 0.04 0.06 0.07 1.22 1.22 1.20 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 0.06 0.43 1.98 2.77 5.56 6.58 4.84 4.58 5.70 5.33 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.00 0.26 0.39 1.09 3.24 2.29 1.94 1.65 2.36 2.67 Sundry Debtors 0.00 0.07 1.58 1.43 2.08 2.28 2.65 2.50 2.43 1.97 Cash & Bank 0.06 0.05 -0.16 0.05 0.17 1.68 0.13 0.22 0.37 0.25 Other Current Assets 0.00 0.05 0.06 0.07 0.07 0.33 0.11 0.22 0.54 0.45 Short Term Loans & Adv. 0.00 0.00 0.10 0.12 0.01 0.00 0.00 0.00 0.00 0.00 Net Current Assets -1.28 -1.49 -1.32 -1.25 -8.96 -5.70 -4.63 -2.21 -0.01 0.39 Total Assets 0.06 4.87 5.63 7.59 21.85 23.36 20.96 18.41 18.63 16.52

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 0.01 0.21 -0.29 -11.34 -0.95 1.05 2.46 0.83 0.39 1.31 PBT -4.23 0.72 -1.28 -3.76 0.03 0.01 0.01 0.01 0.02 0.01 Adjustment 4.45 -0.83 1.06 0.20 0.80 0.90 1.28 0.44 0.99 1.02 Changes in Working Capital -0.20 0.32 -0.07 -7.77 -1.78 0.14 1.17 0.39 -0.62 0.28 Cash after chg. in Working capital 0.01 0.21 -0.29 -11.34 -0.95 1.05 2.46 0.83 0.39 1.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.00 0.00 0.12 11.24 -0.28 -3.03 -3.18 -0.21 -2.44 -1.04 Net Fixed Assets 5.57 0.06 0.66 13.17 -0.28 -0.53 -3.18 -0.21 -2.44 -1.04 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -5.57 -0.06 -0.54 -1.93 0.00 -2.50 0.00 0.00 0.00 0.00 Cash from Financing Activity 0.00 -0.01 -0.03 -0.02 -0.29 3.54 0.63 -0.78 2.18 -0.09 Net Cash Inflow / Outflow 0.01 0.20 -0.21 -0.12 -1.51 1.56 -0.09 -0.15 0.12 0.18 Opening Cash & Equivalents 0.05 -0.16 0.05 0.17 1.68 0.13 0.22 0.37 0.25 0.06 Closing Cash & Equivalent 0.06 0.05 -0.16 0.05 0.17 1.68 0.13 0.22 0.37 0.25

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) -2.68 4.53 3.30 5.49 4.63 4.59 6.11 8.21 9.42 9.04 ROA -171.55% 13.66% -19.42% -25.58% 0.12% 0.01% 0.04% 0.06% 0.13% 0.05% ROE -783.45% 31.35% -49.89% -127.09% 1.02% 0.06% 0.21% 0.20% 0.42% 0.14% ROCE -226.98% 16.18% -23.82% -49.36% 0.93% 2.55% 2.46% 3.16% 3.83% 4.75% Fixed Asset Turnover 0.00 0.13 1.06 0.51 0.29 0.43 1.01 1.12 1.11 1.11 Receivable days 0.00 409.82 86.91 97.25 142.24 110.19 54.74 53.08 52.24 52.95 Inventory Days 0.00 161.32 42.79 119.89 180.36 94.53 38.11 43.20 59.79 78.13 Payable days 0.00 259.87 47.71 84.29 80.83 60.57 37.24 33.50 33.37 26.74 Cash Conversion Cycle 0.00 311.28 81.99 132.85 241.77 144.15 55.61 62.77 78.65 104.33 Total Debt/Equity -0.85 0.50 1.30 0.89 1.97 4.22 2.78 1.88 1.68 1.26 Interest Cover 0.00 92.20 -38.23 -172.43 1.42 1.04 1.04 1.04 1.07 1.02

Top Investors:

hemant amrish parikh

sonal r bambhania

Annual Reports:

News Update:

Adline Chem Lab - Quarterly Results
25th Jan 2024, 15:29 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback